Alan Webster

7.8k citations

33 papers · 5.9k indexed · 2 hit papers · h-index 21

Impact in

Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors

Papers in

Cancer Research 11
- Breast Cancer Treatment Studies 10
Genetics 16
- Estrogen and related hormone effects 16

Co-authors: Aman U. Buzdar Mark L. Steinberg Anthony Howell Stephen E. Jones J.F.R. Robertson Mia von Euler L. Mauriac Ignace Vergote
Journals: Journal of Clinical Oncology (8 papers)Cancer (5 papers)European Journal of Cancer (2 papers)Wildlife Research (2 papers)Lung Cancer (2 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Alan Webster

33 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study 2000 · 606 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Journal of Clinical Oncology
2000 Journal of Clinical Oncology

Peers

Countries citing papers authored by Alan Webster

Since Specialization

Citations

This map shows the geographic impact of Alan Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Webster more than expected).

Fields of papers citing papers by Alan Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Webster. The network helps show where Alan Webster may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan Webster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Webster Line = papers co-authored together Alan Webster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer European Thyroid Journal ·Lars Bastholt, Michael C. Kreißl, Dagmar Führer, Ana Luiza Maia, Laura D. Locati, Léa Maria Zanini Maciel, 信義播磨, Kevin N. Heller, Alan Webster, Rossella Elisei	2016	13
2	KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib Clinical Cancer Research ·Monique B. Nilsson, Uma Giri, Jayanthi Gudikote, Ximing Tang, Wei Lü, Hai T. Tran, You-Hong Fan, Andrew B. Koo, Lixia Diao, Pan Tong, Jing Wang, Roy S. Herbst, Bruce E. Johnson, Andy Ryan, Alan Webster, Philip Rowe, Ignacio I. Wistuba, John V. Heymach	2015	10
3	Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial The Lancet Oncology ·Jean‐Charles Soria, Yi‐Long Wu, Kazuhiko Nakagawa, Sang-We Kim, Jin-Ji Yang, Myung‐Ju Ahn, Jie Wang, James Chih‐Hsin Yang, You Lü, Shinji Atagi, Santiago Ponce, Dae Ho Lee, Yunpeng Liu, Kiyotaka Yoh, Jianying Zhou, Xiaojin Shi, Alan Webster, Haiyi Jiang, Tony Mok	2015	309
4	Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status Journal of Thoracic Oncology ·Jean‐Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor–Eliade Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova, Rose McCormack	2014	348
5	First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study British Journal of Cancer ·Jaime Alberto Santillana Soto, Gyula Ostoros, Manuel Cobo, Tudor–Eliade Ciuleanu, R. McCormack, Alan Webster, Tsveta Milenkova	2013	322
6	Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies British Journal of Dermatology ·윤우성, R. Hoffmann, Alan Webster	2007	20
7	The diet of powerful owls (Ninox strenua) and prey availability in a continuum of habitats from disturbed urban fringe to protected forest environments in south-eastern Australia Wildlife Research ·Raylene Cooke, Robert Wallis, Fiona Hogan, John White, Alan Webster	2006	54
8	O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study Lung Cancer ·Deborah K. Van Den Hoonard, David Bodkin, Ramaswamy Govindan, Bethany Sleckman, Naiyer A. Rizvi, Robert M. Cahill, Paul Germonpré, Isaiah W. Dimery, Alan Webster, Malcolm Ranson	2005	28
9	Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women Cancer ·J.F.R. Robertson, C. Kent Osborne, Anthony Howell, Stephen E. Jones, L. Mauriac, Matthew J. Ellis, Ulrich R. Kleeberg, Steven E. Come, Ignace Vergote, S. Gertler, Aman U. Buzdar, Alan Webster, Charles Morris	2003	241
10	Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment Journal of Clinical Oncology ·Anthony Howell, J.F.R. Robertson, J. Albano, María Teresa Gaspar-Dillanes, L. Mauriac, Ulrich R. Kleeberg, Ignace Vergote, Björn Erikstein, Alan Webster, Caroline Morris	2002	484
11	Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma Cancer ·J. Bonneterre, Aman U. Buzdar, علی اصغر صادقی, John F. R. Robertson, Meng Ran Guan, Mikael von Euler, Tarek Sahmoud, Alan Webster, Mark L. Steinberg	2001	437
12	Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. PubMed ·J.F.R. Robertson, Robert I. Nicholson, Э. П. Белозерова, Elizabeth Anderson, Z Rayter, Mitch Dowsett, John Fox, Julia M.W. Gee, Alan Webster, A. E. Wakeling, Charles Morris, Michael J. Dixon	2001	188
13	Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study Journal of Clinical Oncology ·Jacques Bonneterre, Beat Thürlimann, J.F.R. Robertson, Maciej Krzakowski, L. Mauriac, P. Koralewski, Ignace Vergote, Alan Webster, Mark L. Steinberg, Mia von Euler Hit paper breakdown →	2000	606
14	Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women European Journal of Cancer ·Ignace Vergote, Jacques Bonneterre, Beat Thürlimann, J.F.R. Robertson, Maciej Krzakowski, L. Mauriac, P.V. MALLIKARJUNA REDDY, Alan Webster, Mark L. Steinberg, Mia von Euler	2000	17
15	Diet, Roosts and Breeding of Powerful Owls Ninox strenua in a Disturbed, Urban Environment: A Case for Cannibalism? Or a Case of Infanticide? Emu - Austral Ornithology ·Alan Webster, Raylene Cooke, Jed David, Robert Wallis	1999	15
16	Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma Cancer ·Aman U. Buzdar, W. Jonat, Anthony Howell, Stephen E. Jones, Carl Blomqvist, Charles L. Vogel, W. Eiermann, Janet Wolter, Mark L. Steinberg, Alan Webster, David Lee	1998	129
17	Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma Cancer ·(unknown), Aman U. Buzdar, W. Jonat, Anthony Howell, Stephen E. Jones, Carl Blomqvist, Charles L. Vogel, W. Eiermann, Janet Wolter, Mark L. Steinberg, Alan Webster, David Lee	1998	143
18	Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. Journal of Clinical Oncology ·A. U. Buzdar, W. Jonat, Anthony Howell, Stephen E. Jones, Carl Blomqvist, Charles L. Vogel, W. Eiermann, J Wolter, M. Azab, Alan Webster, JianHao Wu	1996	299
19	ARIMIDEX™: A new oral, once-a-day aromatase inhibitor The Journal of Steroid Biochemistry and Molecular Biology ·Paul V. Plourde, Martin C. Dyroff, Mitch Dowsett, Laurence M. Demers, Roger Yates, Alan Webster	1995	100
20	Diet of powerful owls (Nixox strenua) living near Melbourne, Victoria Wildlife Research ·L.V. Dukanich, Robert Wallis, Alan Webster	1994	18

About Alan Webster

Alan Webster is a scholar working on Cancer Research, Genetics, Oncology, Pulmonary and Respiratory Medicine and Ecological Modeling, having authored 33 papers that have together received 5.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (16 papers), Breast Cancer Treatment Studies (10 papers), Lung Cancer Treatments and Mutations (8 papers), Advanced Breast Cancer Therapies (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Animal Ecology and Behavior Studies (4 papers), Avian ecology and behavior (4 papers) and Wildlife Ecology and Conservation (4 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (3.4k citations), Genetics (3.4k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Obstetrics and Gynecology (197 citations). Alan Webster has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Aman U. Buzdar, Mark L. Steinberg, Anthony Howell, Stephen E. Jones, J.F.R. Robertson, Mia von Euler, L. Mauriac, Ignace Vergote, G. Burton and Charles L. Vogel. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, Wildlife Research and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact